샘플 요청 목록

 카트 문의
시장보고서
상품코드
2015455

북미의 독성학 연구소 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)

North America Toxicology Laboratories Market Insights, Competitive Landscape, and Market Forecast - 2033
발행일: | 리서치사: 구분자 Fairfield Market Research | 페이지 정보: 영문 194 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



가격
Unprintable PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,995 금액 안내 화살표 ￦ 7,353,000
Unprintable PDF & Excel (Multi User License upto 5 users) help
PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.
US $ 8,495 금액 안내 화살표 ￦ 12,505,000
Printable PDF & Excel (Enterprise License above 5 users) help
PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,600 금액 안내 화살표 ￦ 15,604,000
카드담기
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

북미의 독성학 실험실 시장은 첨단 약물 검사, 법의학 분석 및 임상 진단에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다. 이 시장 규모는 2026년에 2억 9,450만 달러로 평가되고 있으며, 2033년에는 6억 1,540만 달러에 달할 것으로 예측되고 있으며, 예측 기간 중 CAGR은 11.10%에 달할 전망입니다. 약물 남용 사례의 증가, 규제 준수 요구 사항 및 기술 발전이 시장 성장에 크게 기여하고 있습니다. 실험실 기반 확인 검사에 대한 의존도가 높아지고 북미 전역의 약물 남용 장애에 대한 부담이 증가함에 따라 시장 수요가 더욱 증가하고 있습니다. 의료 인프라 확충과 정밀진단 솔루션 도입 확대도 산업 성장을 지원하고 있습니다.

시장 인사이트 - 시장에서는 자동화된 독극물 검사 플랫폼과 하이스루풋 스크리닝 기술의 도입이 빠르게 진행되고 있습니다. 크로마토그래피, 면역측정법, 분자진단법의 통합으로 정확성과 효율성이 향상되었습니다. 직장내 약물 검사 요건 강화와 법의학 조사의 증가로 인해 검사 건수가 더욱 증가하고 있습니다. 검사기관에서는 처리시간과 결과의 정확성을 향상시키기 위해 디지털 보고 시스템, 클라우드 기반 데이터 관리, AI를 활용한 분석의 도입이 점점 더 많이 진행되고 있습니다. 다약제 오남용 사례의 복잡성 또한 검사기관의 첨단 멀티 패널 검사 솔루션 도입을 촉진하고 있습니다.

촉진요인 - 주요 촉진요인으로는 약물 및 알코올 남용 사례의 증가, 정부의 엄격한 규제, 정확한 법의학 조사에 대한 수요 증가 등이 있습니다. 임상독성검사의 증가와 병원내 검사실 확대도 시장 성장을 지원하고 있습니다. LC-MS/MS, PCR 기반 검사 등 기술의 발전으로 검출 능력과 업무 효율성이 향상되고 있습니다. 교통, 의료, 기업 부문에서 직장 안전과 의무적인 약물 검사 정책에 대한 인식이 높아지면서 수요가 더욱 가속화되고 있습니다. 공중보건 감시 프로그램에 대한 자금 증액도 시장 확대에 기여하고 있습니다.

비즈니스 기회 - 검사실 자동화, 재활센터 확장, 독성검사 서비스 아웃소싱 등에는 큰 비즈니스 기회가 존재합니다. 신속한 현장(POC) 독극물 검사에 대한 수요 증가는 새로운 수입원을 창출하고 있습니다. 민간 진단 기업은 검사의 민감도와 속도를 향상시키기 위해 첨단 장비와 시약의 혁신에 투자하고 있습니다. 형사 사법 시스템에서 법과학의 적용 확대도 새로운 성장의 길을 열어주고 있습니다. 맞춤형 의료가 확산됨에 따라 고도화된 독성 프로파일링에 대한 수요는 더욱 증가할 것으로 예상됩니다.

지역 분석 - 미국은 첨단화된 의료 인프라, 높은 검사 건수, 강력한 규제 프레임워크로 북미 독극물 검사 시장을 독점하고 있습니다. 캐나다에서도 약물 남용 모니터링에 대한 의식의 향상와 정부 주도의 의료 구상에 힘입어 꾸준한 성장세를 보이고 있습니다. 진단 검사 네트워크의 확대와 공중 보건 프로그램에 대한 투자 증가는 북미 전역의 지역 성장을 지속적으로 지원하고 있습니다.

주요 기업:

  • Thermo Fisher Scientific, Inc.
  • Bio Rad Laboratories Inc.
  • Neogen Corporation
  • Danaher Corporation
  • Agilent
  • Redwood Toxicology Laboratory
  • Abbott(Alere, Inc.)

세분화:

약물 분류:

  • 알코올
  • 암페타민
  • 바르비투르산계
  • 벤조디아제핀계
  • 불법 약물
  • 오피오이드/오피오이드
  • 삼환계 항우울제
  • Z계 약물
  • 기타

제품 유형:

  • 시약 키트
  • ELISA
  • PCR
  • 효소증폭면역측정법(EMIT)
  • 방사선 면역측정법(RIA)
  • 장비
  • 면역화학 분석기
  • PCR 장비
  • 가스 크로마토그래피/질량분석(GC/MS)
  • 고성능 액체 크로마토그래피(HPLC)

표본:

  • 소변
  • 혈액
  • 머리카락
  • 구강액

최종사용자:

  • 병원
  • 진료소
  • 진단검사실
  • 법의학 검사실
  • 재활센터

지역별:

  • 북미
  • 미국
  • 캐나다

목차

제1장 개요

제2장 시장 개요

제3장 북미의 독성학 연구소 시장 전망, 2020-2033년

제4장 북미의 독성학 연구소 시장 전망, 2020-2033년

제5장 유럽의 독성학 연구소 시장 전망, 2020-2033년

제6장 아시아태평양의 독성학 연구소 시장 전망, 2020-2033년

제7장 라틴아메리카의 독성학 연구소 시장 전망, 2020-2033년

제8장 중동 및 아프리카의 독성학 연구소 시장 전망, 2020-2033년

제9장 경쟁 구도

제10장 부록

KSA

The North America Toxicology Laboratories Market is witnessing robust expansion driven by increasing demand for advanced drug testing, forensic analysis, and clinical diagnostics. The market is valued at 294.5 mn in 2026 and is projected to reach 615.4 mn in 2033, registering a CAGR of 11.10% during the forecast period. Rising substance abuse cases, regulatory compliance requirements, and technological advancements are significantly contributing to market growth. Increasing reliance on laboratory-based confirmation testing and the growing burden of substance misuse disorders across North America are further strengthening market demand. Expansion of healthcare infrastructure and rising adoption of precision diagnostic solutions are also supporting industry growth.

Market Insights: The market is experiencing strong adoption of automated toxicology testing platforms and high-throughput screening technologies. Integration of chromatography, immunoassays, and molecular diagnostics is enhancing accuracy and efficiency. Increasing workplace drug screening requirements and forensic investigations are further driving testing volumes. Laboratories are increasingly adopting digital reporting systems, cloud-based data management, and AI-assisted analytics to improve turnaround time and result accuracy. Growing complexity of poly-drug abuse cases is also pushing laboratories to adopt advanced multi-panel testing solutions.

Drivers: Key drivers include rising drug and alcohol abuse cases, stringent government regulations, and increasing need for accurate forensic investigations. Growth in clinical toxicology testing and expansion of hospital-based laboratories are also supporting market growth. Technological advancements such as LC-MS/MS and PCR-based testing are improving detection capabilities and operational efficiency. Rising awareness regarding workplace safety and mandatory drug testing policies in transportation, healthcare, and corporate sectors are further accelerating demand. Increased funding for public health surveillance programs is also contributing to market expansion.

Business Opportunity: Significant opportunities exist in laboratory automation, expansion of rehabilitation centers, and outsourcing of toxicology testing services. Growing demand for rapid, point-of-care toxicology screening is creating new revenue streams. Private diagnostic companies are investing in advanced instrumentation and reagent innovation to improve testing sensitivity and speed. Expansion of forensic science applications in criminal justice systems is also opening new growth avenues. Increasing adoption of personalized medicine is expected to further enhance demand for advanced toxicology profiling.

Region Analysis: The United States dominates the North America Toxicology Laboratories Market due to advanced healthcare infrastructure, high testing volumes, and strong regulatory frameworks. Canada is also witnessing steady growth driven by increasing awareness of substance abuse monitoring and government-led healthcare initiatives. Expansion of diagnostic laboratory networks and rising investment in public health programs continue to support regional growth across North America.

Key Players:

  • Thermo Fisher Scientific, Inc.
  • Bio Rad Laboratories Inc.
  • Neogen Corporation
  • Danaher Corporation
  • Agilent
  • Redwood Toxicology Laboratory
  • Abbott (Alere, Inc.)

Segmentation:

Drug Class:

  • Alcohol
  • Amphetamines
  • Barbiturates
  • Benzodiazepines
  • Illicit Drugs
  • Opiates/Opioids
  • Tricyclic's Antidepressants
  • Z Drugs
  • Misc

Product Type:

  • Reagent Kits
  • ELISA
  • PCR
  • Enzyme Multiplied Immunoassay Technique (EMIT)
  • Radio Immuno-sorbent Assay (RIA)
  • Instruments
  • Immunochemistry Analyzers
  • PCR Machine
  • Gas Chromatography/Mass Spectrometry (GS/MS)
  • High Performance Liquid Chromatography (HPLC)

Sample:

  • Urine
  • Blood
  • Hair
  • Oral Fluid

End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Rehabilitation Centers

By Geographic Coverage:

  • North America
  • U.S.
  • Canada

Table of Contents

1. Executive Summary

  • 1.1. Global North America Toxicology Laboratories Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global North America Toxicology Laboratories Market Outlook, 2020-2033

  • 3.1. Global North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 3.1.1. Alcohol
    • 3.1.2. Amphetamines
    • 3.1.3. Barbiturates
    • 3.1.4. Barbiturates
    • 3.1.5. Benzodiazepines
    • 3.1.6. Illicit Drugs
    • 3.1.7. Opiates/Opioids
    • 3.1.8. Tricyclic's Antidepressants
    • 3.1.9. Z Drugs
    • 3.1.10. Misc
  • 3.2. Global North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 3.2.1. Reagent Kits
      • 3.2.1.1. ELISA
      • 3.2.1.2. PCR
      • 3.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 3.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 3.2.2. Instruments
      • 3.2.2.1. Immunochemistry Analyzers
      • 3.2.2.2. PCR Machine
      • 3.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 3.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 3.3. Global North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 3.3.1. Urine
    • 3.3.2. Blood
    • 3.3.3. Hair
    • 3.3.4. Oral Fluid
  • 3.4. Global North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 3.4.1. Hospitals
    • 3.4.2. Clinics
    • 3.4.3. Diagnostic Laboratories
    • 3.4.4. Forensic Laboratories
    • 3.4.5. Rehabilitation Centers
  • 3.5. Global North America Toxicology Laboratories Market Outlook, by Region, Value (US$ Mn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America North America Toxicology Laboratories Market Outlook, 2020-2033

  • 4.1. North America North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 4.1.1. Alcohol
    • 4.1.2. Amphetamines
    • 4.1.3. Barbiturates
    • 4.1.4. Barbiturates
    • 4.1.5. Benzodiazepines
    • 4.1.6. Illicit Drugs
    • 4.1.7. Opiates/Opioids
    • 4.1.8. Tricyclic's Antidepressants
    • 4.1.9. Z Drugs
    • 4.1.10. Misc
  • 4.2. North America North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 4.2.1. Reagent Kits
      • 4.2.1.1. ELISA
      • 4.2.1.2. PCR
      • 4.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 4.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 4.2.2. Instruments
      • 4.2.2.1. Immunochemistry Analyzers
      • 4.2.2.2. PCR Machine
      • 4.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 4.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 4.3. North America North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 4.3.1. Urine
    • 4.3.2. Blood
    • 4.3.3. Hair
    • 4.3.4. Oral Fluid
  • 4.4. North America North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 4.4.1. Hospitals
    • 4.4.2. Clinics
    • 4.4.3. Diagnostic Laboratories
    • 4.4.4. Forensic Laboratories
    • 4.4.5. Rehabilitation Centers
  • 4.5. North America North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 4.5.1. U.S. North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 4.5.2. U.S. North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 4.5.3. U.S. North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 4.5.4. U.S. North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 4.5.5. Canada North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 4.5.6. Canada North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 4.5.7. Canada North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 4.5.8. Canada North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe North America Toxicology Laboratories Market Outlook, 2020-2033

  • 5.1. Europe North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 5.1.1. Alcohol
    • 5.1.2. Amphetamines
    • 5.1.3. Barbiturates
    • 5.1.4. Barbiturates
    • 5.1.5. Benzodiazepines
    • 5.1.6. Illicit Drugs
    • 5.1.7. Opiates/Opioids
    • 5.1.8. Tricyclic's Antidepressants
    • 5.1.9. Z Drugs
    • 5.1.10. Misc
  • 5.2. Europe North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 5.2.1. Reagent Kits
      • 5.2.1.1. ELISA
      • 5.2.1.2. PCR
      • 5.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 5.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 5.2.2. Instruments
      • 5.2.2.1. Immunochemistry Analyzers
      • 5.2.2.2. PCR Machine
      • 5.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 5.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 5.3. Europe North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 5.3.1. Urine
    • 5.3.2. Blood
    • 5.3.3. Hair
    • 5.3.4. Oral Fluid
  • 5.4. Europe North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 5.4.1. Hospitals
    • 5.4.2. Clinics
    • 5.4.3. Diagnostic Laboratories
    • 5.4.4. Forensic Laboratories
    • 5.4.5. Rehabilitation Centers
  • 5.5. Europe North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 5.5.1. Germany North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.2. Germany North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.3. Germany North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.4. Germany North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.5. Italy North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.6. Italy North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.7. Italy North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.8. Italy North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.9. France North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.10. France North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.11. France North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.12. France North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.13. U.K. North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.14. U.K. North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.15. U.K. North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.16. U.K. North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.17. Spain North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.18. Spain North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.19. Spain North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.20. Spain North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.21. Russia North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.22. Russia North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.23. Russia North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.24. Russia North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 5.5.25. Rest of Europe North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 5.5.26. Rest of Europe North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 5.5.27. Rest of Europe North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 5.5.28. Rest of Europe North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific North America Toxicology Laboratories Market Outlook, 2020-2033

  • 6.1. Asia Pacific North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 6.1.1. Alcohol
    • 6.1.2. Amphetamines
    • 6.1.3. Barbiturates
    • 6.1.4. Barbiturates
    • 6.1.5. Benzodiazepines
    • 6.1.6. Illicit Drugs
    • 6.1.7. Opiates/Opioids
    • 6.1.8. Tricyclic's Antidepressants
    • 6.1.9. Z Drugs
    • 6.1.10. Misc
  • 6.2. Asia Pacific North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 6.2.1. Reagent Kits
      • 6.2.1.1. ELISA
      • 6.2.1.2. PCR
      • 6.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 6.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 6.2.2. Instruments
      • 6.2.2.1. Immunochemistry Analyzers
      • 6.2.2.2. PCR Machine
      • 6.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 6.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 6.3. Asia Pacific North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 6.3.1. Urine
    • 6.3.2. Blood
    • 6.3.3. Hair
    • 6.3.4. Oral Fluid
  • 6.4. Asia Pacific North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 6.4.1. Hospitals
    • 6.4.2. Clinics
    • 6.4.3. Diagnostic Laboratories
    • 6.4.4. Forensic Laboratories
    • 6.4.5. Rehabilitation Centers
  • 6.5. Asia Pacific North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 6.5.1. China North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.2. China North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.3. China North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.4. China North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.5. Japan North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.6. Japan North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.7. Japan North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.8. Japan North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.9. South Korea North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.10. South Korea North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.11. South Korea North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.12. South Korea North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.13. India North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.14. India North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.15. India North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.16. India North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.17. Southeast Asia North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.18. Southeast Asia North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.19. Southeast Asia North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.20. Southeast Asia North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 6.5.21. Rest of SAO North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 6.5.22. Rest of SAO North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 6.5.23. Rest of SAO North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 6.5.24. Rest of SAO North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America North America Toxicology Laboratories Market Outlook, 2020-2033

  • 7.1. Latin America North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 7.1.1. Alcohol
    • 7.1.2. Amphetamines
    • 7.1.3. Barbiturates
    • 7.1.4. Barbiturates
    • 7.1.5. Benzodiazepines
    • 7.1.6. Illicit Drugs
    • 7.1.7. Opiates/Opioids
    • 7.1.8. Tricyclic's Antidepressants
    • 7.1.9. Z Drugs
    • 7.1.10. Misc
  • 7.2. Latin America North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 7.2.1. Reagent Kits
      • 7.2.1.1. ELISA
      • 7.2.1.2. PCR
      • 7.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 7.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 7.2.2. Instruments
      • 7.2.2.1. Immunochemistry Analyzers
      • 7.2.2.2. PCR Machine
      • 7.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 7.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 7.3. Latin America North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 7.3.1. Urine
    • 7.3.2. Blood
    • 7.3.3. Hair
    • 7.3.4. Oral Fluid
  • 7.4. Latin America North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Diagnostic Laboratories
    • 7.4.4. Forensic Laboratories
    • 7.4.5. Rehabilitation Centers
  • 7.5. Latin America North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 7.5.1. Brazil North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 7.5.2. Brazil North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 7.5.3. Brazil North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 7.5.4. Brazil North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 7.5.5. Mexico North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 7.5.6. Mexico North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 7.5.7. Mexico North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 7.5.8. Mexico North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 7.5.9. Argentina North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 7.5.10. Argentina North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 7.5.11. Argentina North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 7.5.12. Argentina North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 7.5.13. Rest of LATAM North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 7.5.14. Rest of LATAM North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 7.5.15. Rest of LATAM North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 7.5.16. Rest of LATAM North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa North America Toxicology Laboratories Market Outlook, 2020-2033

  • 8.1. Middle East & Africa North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2020-2033
    • 8.1.1. Alcohol
    • 8.1.2. Amphetamines
    • 8.1.3. Barbiturates
    • 8.1.4. Barbiturates
    • 8.1.5. Benzodiazepines
    • 8.1.6. Illicit Drugs
    • 8.1.7. Opiates/Opioids
    • 8.1.8. Tricyclic's Antidepressants
    • 8.1.9. Z Drugs
    • 8.1.10. Misc
  • 8.2. Middle East & Africa North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2020-2033
    • 8.2.1. Reagent Kits
      • 8.2.1.1. ELISA
      • 8.2.1.2. PCR
      • 8.2.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
      • 8.2.1.4. Radio Immuno-sorbent Assay (RIA)
    • 8.2.2. Instruments
      • 8.2.2.1. Immunochemistry Analyzers
      • 8.2.2.2. PCR Machine
      • 8.2.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
      • 8.2.2.4. High Performance Liquid Chromatography (HPLC)
  • 8.3. Middle East & Africa North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2020-2033
    • 8.3.1. Urine
    • 8.3.2. Blood
    • 8.3.3. Hair
    • 8.3.4. Oral Fluid
  • 8.4. Middle East & Africa North America Toxicology Laboratories Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 8.4.1. Hospitals
    • 8.4.2. Clinics
    • 8.4.3. Diagnostic Laboratories
    • 8.4.4. Forensic Laboratories
    • 8.4.5. Rehabilitation Centers
  • 8.5. Middle East & Africa North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 8.5.1. GCC North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.2. GCC North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.3. GCC North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.4. GCC North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 8.5.5. South Africa North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.6. South Africa North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.7. South Africa North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.8. South Africa North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 8.5.9. Egypt North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.10. Egypt North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.11. Egypt North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.12. Egypt North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 8.5.13. Nigeria North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.14. Nigeria North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.15. Nigeria North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.16. Nigeria North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
    • 8.5.17. Rest of Middle East North America Toxicology Laboratories Market Outlook, by Drug Class, 2020-2033
    • 8.5.18. Rest of Middle East North America Toxicology Laboratories Market Outlook, by Product Type, 2020-2033
    • 8.5.19. Rest of Middle East North America Toxicology Laboratories Market Outlook, by Sample, 2020-2033
    • 8.5.20. Rest of Middle East North America Toxicology Laboratories Market Outlook, by End User, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Bio Rad Laboratories Inc.
    • 9.4.3. Neogen Corporation
    • 9.4.4. Danaher Corporation
    • 9.4.5. Agilent
    • 9.4.6. Redwood Toxicology Laboratory
    • 9.4.7. Abbott (Alere, Inc.)

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기